Treatment with the KCa3.1 inhibitor TRAM‐34 during diabetic ketoacidosis reduces inflammatory changes in the brain

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles